Stock Price
74.83
Daily Change
0.41 0.55%
Monthly
8.64%
Yearly
0.97%
Q2 Forecast
71.86

Solventum Corp reported $437M in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Abbott USD 3.27B 178M Dec/2025
Align Technology USD 260.87M 77.03M Dec/2025
Baxter International USD -447M 873M Dec/2025
Becton, Dickinson and Co. USD 1.71B 433M Dec/2025
Cencora USD 1.2B 42.41M Dec/2025
Dexcom USD 364.5M 57.7M Mar/2026
Insulet USD 181.7M 12.3M Mar/2026
Solventum Corp USD 437M 0 Mar/2026
West Pharmaceutical Services USD 226.2M 7.7M Mar/2026
Zimmer Biomet Holdings USD 759M 120.8M Dec/2025